Allurion Technologies Inc. (NYSE:ALUR – Get Free Report)’s stock price dropped 3.8% during trading on Wednesday . The company traded as low as $0.68 and last traded at $0.71. Approximately 166,539 shares changed hands during trading, a decline of 78% from the average daily volume of 769,056 shares. The stock had previously closed at $0.74.
Analysts Set New Price Targets
Several equities analysts recently weighed in on the company. Roth Mkm started coverage on Allurion Technologies in a research note on Friday, September 6th. They issued a “buy” rating and a $2.00 price target for the company. TD Cowen began coverage on Allurion Technologies in a research note on Wednesday, October 2nd. They set a “buy” rating and a $2.00 target price for the company. Roth Capital raised shares of Allurion Technologies to a “strong-buy” rating in a research note on Friday, September 6th. Finally, Chardan Capital reduced their price objective on shares of Allurion Technologies from $5.00 to $2.50 and set a “buy” rating for the company in a research report on Thursday, August 22nd. Four analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Buy” and an average price target of $2.88.
Read Our Latest Stock Report on ALUR
Allurion Technologies Price Performance
Allurion Technologies (NYSE:ALUR – Get Free Report) last announced its earnings results on Tuesday, August 13th. The company reported $0.01 earnings per share (EPS) for the quarter. The business had revenue of $11.77 million for the quarter. As a group, research analysts forecast that Allurion Technologies Inc. will post -0.4 earnings per share for the current year.
Institutional Inflows and Outflows
An institutional investor recently raised its position in Allurion Technologies stock. Accredited Investors Inc. increased its position in shares of Allurion Technologies Inc. (NYSE:ALUR – Free Report) by 33.3% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 50,000 shares of the company’s stock after purchasing an additional 12,500 shares during the period. Accredited Investors Inc. owned 0.10% of Allurion Technologies worth $50,000 at the end of the most recent quarter. Institutional investors and hedge funds own 21.39% of the company’s stock.
About Allurion Technologies
Allurion Technologies Inc focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite.
Featured Articles
- Five stocks we like better than Allurion Technologies
- EV Stocks and How to Profit from Them
- Chinese Stocks Cool Off: Time to Buy the Dip in These 2 Stocks?
- How to Use the MarketBeat Excel Dividend Calculator
- Goldman Sachs Highlights 3 Top Short Squeeze Stocks to Watch
- Stock Average Calculator
- Walmart is Up 56% YTD, Is it Still a Top Consumer Staples Stock?
Receive News & Ratings for Allurion Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allurion Technologies and related companies with MarketBeat.com's FREE daily email newsletter.